Jpmorgan Chase & CO Volitionrx LTD Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$0.59 - $0.91 $0 - $0
1 New
1 $0
Q4 2023

Feb 12, 2024
BUY
$0.55 - $0.88 $983 - $1,573
1,788 Added 178800.0%
1,789 $1,000
Q3 2023

Nov 14, 2023
SELL
$0.69 - $1.53 $11,669 - $25,876
-16,913 Reduced 99.99%
1 $0
Q2 2023

Aug 11, 2023
SELL
$1.39 - $2.02 $29,199 - $42,434
-21,007 Reduced 55.4%
16,914 $23,000
Q1 2023

May 11, 2023
BUY
$1.54 - $2.68 $58,398 - $101,628
37,921 New
37,921 $72,000

Others Institutions Holding VNRX

# of Institutions
26
Shares Held
17.8M
Call Options Held
41K
Put Options Held
100
View Full List

About VOLITIONRX LTD

VNRX Quotes by TradingView
  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $39M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email